top of page
Paul Case.JPG

WHAT'S OUR MOTIVATION?

We want to help.

Covid-19 has overwhelmed healthcare systems worldwide. We’ve all seen the images of people clinging onto their lives in the crowded hospitals of the developed world. But, what about the developing world? Although we don’t hear much about them in mainstream media, they need our help more than ever! 

  

Sentient Bionics decided to do something about this in March 2020. In a massive philanthropic effort, the young and passionate team developed SentOx. Not only does it cost a fraction of conventional systems, but the SentOx Oxygen Concentrator is also rugged and incredibly portable - ideal for disaster management and the challenging medical environments of the developing world.  

OUR GOAL

In countries such as India, Indonesia and South Africa medical equipment is scarce, expensive and often inaccessible to the disadvantaged. Severe Covid-19 patients require medical grade oxygen to have a better chance of survival. The World Health Organisation (WHO) predicts that 32-million people will require oxygen therapy in the next 18 months. Many of these patients will be in the developing world, where conventional oxygen concentrators are far too expensive and more rudimentary methods such as oxygen storage tanks are utilised. The developing world is in desperate need of a better solution.

That is why the Sentient team developed an oxygen concentrator machine aimed at helping the developing world's hospitals and clinics. It's called SentOx and it's designed to World Health Organisation specifications! To date, we've developed 20 fully functional SentOx units and have shipped off our first units to partners in Indonesia, South Africa and Australia.

Our product is different for so many important reasons:

  • It can be made in-country, cheaply and easily.

  • Very little upfront capital expenditure is needed to set up a manufacturing facility for SentOx devices (you don’t need specialized machines).

  • You can assemble and repair the SentOx with basic tools.

  • Our business model of technology transfer is beneficial because it helps the people who are sick and desperately need oxygen and local economies by enabling them to support themselves better during this pandemic and afterwards.

042A5016%20(2)_edited.jpg
SentOx South Africa.jpg

TIMELINE

The developing world will be battling Covid-19 for many years to come. Aside from Covid-19, SentOx will provide important oxygen therapy to patients suffering from chronic pneumonia, malaria, asthma and many other diseases.

 

We've fine-tuned the design of SentOx, have 20 functioning prototypes and are ready to start saving lives! We already sent our first units to South Africa, Australia and Indonesia.

In September 2021, we sent a unit to AFDA- Australian Doctors for Africa in Perth! They reviewed our product and gave us valued feedback.

In November 2021, we sent a unit to our partner: Foxolution, in South Africa. In January 2022, Foxolution has agreed to sign SentOx’s Licence agreement. SentOx has a manufacturing site in  South Africa!

 

In order to reach our goal of saving one million lives, we need to deploy over 7000 SentOx Oxygen Concentrators to the developing world in the next months. You can be a partner in helping us save lives by donating directly or to our GoFundMe Campaign

Do you want to manufacture or distribute SentOx in your country and help your people and economy? Send us an email to let us know.

ACNC-Registered-Charity-Logo_RGB.png

We are a registered Australian charity.

bottom of page